- Report
- June 2022
- 225 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Book
- May 2016
- 512 Pages
- Book
- April 2015
- 384 Pages

The Neurologic Disease market is a subset of the larger Neurology field, which focuses on the diagnosis and treatment of diseases of the nervous system. This includes conditions such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and stroke. Neurologic Disease treatments range from medications to physical and occupational therapy, and may also include lifestyle changes such as diet and exercise.
The Neurologic Disease market is highly competitive, with a variety of companies offering products and services to meet the needs of patients. These include pharmaceutical companies such as Pfizer, Merck, and Novartis; medical device companies such as Medtronic and St. Jude Medical; and biotechnology companies such as Genentech and Biogen. Additionally, there are a number of smaller companies that specialize in specific areas of Neurologic Disease, such as stem cell therapy and gene therapy. Show Less Read more